Pharmafile Logo
Pharmafocus logo
Advanced Search

Er-Kim

Showing 2 posts of 2 posts found.

Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey

August 29, 2025
Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care

Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …

News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021
Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025